No abstract is provided for this article.
Interest in the use of wire arc additive manufacturing (WAAM) in construction has increased rapidly in recent years. Key to facilitating wider application is an improved understanding of the material behaviour. In particular, with structural design by finite element analysis in mind, constitutive models to describe the full range stress-strain response of WAAM steels are needed; development of such models is the focus of the present study. WAAM normal-strength steels generally exhibit a stress-strain response featuring a well-defined yield point, a yield plateau (for machined material) or slightly inclined yield plateau (for as-built material) and subsequent strain hardening, while the stress-strain response of WAAM high-strength steels is typically rounded, with no distinct yield point or plateau. This behaviour is similar to that of conventionally-produced steels, and hence can be represented analytically using existing material models, but with suitable modifications — a quad-linear or bilinear plus nonlinear hardening model and a two-stage Ramberg-Osgood model are proposed for WAAM normal- and high-strength steels, respectively. Predictive expressions or standardised values for the input parameters required in the models are developed and calibrated against a comprehensive database of WAAM steel coupon test results collected from the literature. The experimental database comprises over 600 engineering stress-strain curves and covers different feedstock wires, surface finishes (i.e. machined and as-built), material thicknesses, directions of testing and printing strategies. The proposed material models are shown to accurately predict the full stress-strain curves of WAAM steels, and are considered to be suitable for incorporation into analytical, numerical and design models for WAAM steel structures.
The Census of High- and Medium-mass Protostars (CHaMP) is the first large-scale, unbiased, uniform mapping survey at sub-parsec scale resolution of 90 GHz line emission from massive molecular clumps in the Milky Way. We present the first Mopra (ATNF) maps of the CHaMP survey region (300{\deg}>l>280{\deg}) in the HCO+ J=1-0 line, which is usually thought to trace gas at densities up to 10^11 m-3. In this paper we introduce the survey and its strategy, describe the observational and data reduction procedures, and give a complete catalogue of moment maps of the HCO+ J=1-0 emission from the ensemble of 301 massive molecular clumps. From these maps we also derive the physical parameters of the clumps, using standard molecular spectral-line analysis techniques. This analysis yields the following range of properties: integrated line intensity 1-30 K km s-1, peak line brightness 1-7 K, linewidth 1-10 km s-1, integrated line luminosity 0.5-200 K km s-1 pc^2, FWHM size 0.2-2.5 pc, mean projected axial ratio 2, optical depth 0.08-2, total surface density 30-3000 M{\sun} pc-2, number density 0.2-30 x 10^9 m-3, mass 15-8000 M{\sun}, virial parameter 1-55, and total gas pressure 0.3-700 pPa. We find that the CHaMP clumps do not obey a Larson-type size-linewidth relation. Among the clumps, there exists a large population of subthermally excited, weakly-emitting (but easily detectable) dense molecular clumps, confirming the prediction of Narayanan et al. (2008). These weakly-emitting clumps comprise 95% of all massive clumps by number, and 87% of the molecular mass, in this portion of the Galaxy; their properties are distinct from the brighter massive star-forming regions that are more typically studied. If the clumps evolve by slow contraction, the 95% of fainter clumps may represent a long-lived stage of pressure-confined, gravitationally stable massive clump evolution, while the CHaMP ... (abridged)
Coronary stents have revolutionized the management of patients with obstructive coronary artery disease. This chapter will review the problems associated with percutaneous coronary intervention when performed using balloon angioplasty and bare-metal stents, before discussing the first and second generation drug-eluting stents (DESs). Finally, the new generation of DESs, which are currently undergoing evaluation in clinical trials, will be reviewed.